Harper Sean E 4
4 · AMGEN INC · Filed Mar 19, 2018
Insider Transaction Report
Form 4
AMGEN INCAMGN
Harper Sean E
EVP, Research & Development
Transactions
- Sale
Common Stock
2018-03-16$189.75/sh−1,525$289,369→ 65,682 total
Footnotes (3)
- [F1]The transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1.
- [F2]These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,340 RSUs which vest in one installment on 1/30/2019; 4,477 RSUs which vest in two equal installments of 1,477 on 5/3/2018 and 5/3/2019 and one installment of 1,523 on 5/3/2020; and 4,551 RSUs which vest in installments of 1,501 on 5/1/2019, 1,502 on 5/1/2029 and 1,548 on 5/1/2021. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
- [F3]These shares include 403 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.